In this podcast episode, our experts explore how these differ and what their roles are when it comes to data management in the lab.
In this podcast episode, our experts discuss the changing face of medicine and what it means for patients.
A Legacy System Approach Isn’t Suitable for Modern Biopharma Development. Here Are Four Reasons Why.
Modern biopharma development requires more than just a LIMS and spreadsheets. Learn why in this article by Alberto Pascual, IDBS, featuring Accenture and published in Lab Manager.
Therapies are more complex, tailored and varied than ever and the associated amount of data is growing – which requires a new level of attention to detail.
Gain key insights on the value of using purpose-built software systems to streamline your critical manufacturing data management and product quality processes across internal and external networks.
IDBS announces the latest release of its Skyland PIMS® software, which seamlessly combines product, process, and patient data across the biopharma life cycle and supply chain, providing insights that accelerate process understanding and ensure product quality.
The current state of biopharma drug development is a barrier to the timely and cost-effective treatment of disease.
BioPharma Lifecycle Management (BPLM) and the impact of technology In this podcast episode, Scitara’s Dave Levy is joined by Craig Williamson, Platform Product Owner at IDBS. Scitara Connect discusses the importance of a successful digital transformation strategy in the…
Skyland PIMS version 4.2 introduces new capabilities to accelerate biopharma development and manufacturing by eliminating barriers to data and expanding statistical analysis to further enhance monitoring of processes across modalities, including cell and gene therapies, small molecule, and other biologics.
It’s been a busy year so far. And we’re only at the start of April! Find out what we’ve been up to in this blog.